Graeme Bell
2018
In 2018, Graeme Bell earned a total compensation of $1.6M as Former Executive Vice President, Chief Financial Officer at Intellia Therapeutics, a 59% decrease compared to previous year.
Compensation breakdown
| Option Awards | $934,182 |
|---|---|
| Salary | $265,431 |
| Stock Awards | $337,238 |
| Other | $25,857 |
| Total | $1,562,708 |
Bell received $934.2K in option awards, accounting for 60% of the total pay in 2018.
Bell also received $265.4K in salary, $337.2K in stock awards and $25.9K in other compensation.
Rankings
In 2018, Graeme Bell's compensation ranked 6,958th out of 14,244 executives tracked by ExecPay. In other words, Bell earned more than 51.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,958 out of 14,244 | 51st |
Division Manufacturing | 2,673 out of 5,759 | 54th |
Major group Chemicals And Allied Products | 1,007 out of 2,122 | 53rd |
Industry group Drugs | 846 out of 1,811 | 53rd |
Industry In Vitro and In Vivo Diagnostic Substances | 23 out of 72 | 68th |
Source: SEC filing on April 16, 2019.
Bell's colleagues
We found four more compensation records of executives who worked with Graeme Bell at Intellia Therapeutics in 2018.